Prime Therapeutics is challenging traditional thinking in the PBM industry with its new MedsYourWay offering. This new shopping experience under MedsYourWay gives participating Blue Plans’ members a customer-centric home delivery prescription option using Amazon Pharmacy paired with an integrated MedsYourWay prescription discount card administered by Inside. Purchases of prescribed and covered medications automatically count toward member out-of-pocket maximums. Prime Therapeutics is the first PBM to announce this innovative home delivery option in the marketplace.
Prime Therapeutics is uniquely positioned to offer a variety of solutions; it is not locked into offerings governed by one relationship. Other PBMs may want to drive toward their owned home delivery option, but Prime Therapeutics is able to offer what is most cost-effective and convenient for its health plan clients and their members.
MedsYourWay represents channel independence and an unbiased approach in identifying the best consumer solutions that allow Blue Plan members easy access to low-cost medications. The first MedsYourWay offering for home delivery using Amazon Pharmacy represents how Prime Therapeutics does business with its Blue Plan partners.
Fast and easy choice for more satisfying user experience
To solve for gaps in the home delivery and drug discount card user experiences, MedsYourWay offers members access to a personalized shopping experience at Amazon Pharmacy where they receive:
Medicines work best when they’re taken as prescribed. A study published in Journal of Managed Care & Specialty Pharmacy showed an estimated 59% improved adherence for consumers using home delivery for their medicines. Through offerings including MedsYourWay, Prime Therapeutics is committed to making it easier for members to get the medicines they need to feel better and live well.
The power of Blue + Prime Therapeutics integration
Blue Plans are actively engaged in the development of MedsYourWay as part of
the Prime Therapeutics expansive product innovation discipline. Prime Therapeutics’ clients embrace consumer-focused offerings including MedsYourWay that enable them
to deliver a differentiated product to their members. Its model and the actions Prime Therapeutics takes every day on behalf of health plans and members demonstrate integration goes beyond pharmacy and medical data to encompass key elements including member experience.
Initially focused on the commercial market, MedsYourWay will be available to Prime Therapeutic’s clients beginning Jan. 1, 2022. Future breakthrough consumer shopping experiences will be launched under the MedsYourWay offering.
Jarrod Henshaw, President, Chief Innovation and Supply Chain Officer
As senior vice president, chief innovation and supply chain officer, for Prime Therapeutics (Prime), Jarrod Henshaw sets
the vision and provides strategic oversight for trade relations with pharmaceutical manufacturers, network management, pharmacy audit, and fraud, waste and abuse (FWA).
Henshaw comes to Prime with more than 20 years’ experience in the healthcare sector. Prior to joining Prime, he held leadership roles at Healogics, including chief innovation officer, executive vice president of supply chain and chief legal officer. Prior to that, Henshaw spent 14 years at Express Scripts (now Cigna), where he served as chief strategy officer of supply chain and deputy general counsel.
Henshaw earned a Bachelor of Arts degree in political science from the University of Illinois at Urbana-Champaign, Illinois, and a Doctorate of Law from Saint Louis University in St. Louis.
REFERENCES
Kindred Hospitals: A Critical Level of Care
August 8th 2024Intensive Care Units in long-term acute care hospitals (LTACHs) treat many of the same conditions that traditional ICUs treat but are designed to do so for a longer period of time. Not only is it possible for LTACHs to treat patients with these conditions but these specialized hospitals are also able to achieve lower readmission rates for more complex patients. In this article you will discover: · The top conditions treated at both traditional ICUs and LTACHs · Readmission rates of complex patients discharging from both settings · Characteristics of Kindred Hospitals’ LTACHs that allow them to provide exceptional critical care
Read More